Authors’ Reply: Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation?

Norberto Perico; Matthew D. Griffin; Federica Casiraghi; Giuseppe Remuzzi

doi:10.1681/ASN.0000000000000231

Authors’ Reply: Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation?

Norberto Perico
, Matthew D. Griffin
, Federica Casiraghi
, Giuseppe Remuzzi

Medicine

Department of Neuroscience

Research output: Contribution to a Journal (Peer & Non Peer) › Letter › peer-review

Original language	English
Pages (from-to)	2052-2053
Number of pages	2
Journal	Journal of the American Society of Nephrology
Volume	34
Issue number	12
DOIs	https://doi.org/10.1681/ASN.0000000000000231
Publication status	Published - 1 Dec 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1681/ASN.0000000000000231

Cite this

@article{4f7bbd42555044d48e2be176b83e5aae,

title = "Authors{\textquoteright} Reply: Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation?",

author = "Norberto Perico and Griffin, \{Matthew D.\} and Federica Casiraghi and Giuseppe Remuzzi",

year = "2023",

month = dec,

day = "1",

doi = "10.1681/ASN.0000000000000231",

language = "English",

volume = "34",

pages = "2052--2053",

journal = "Journal of the American Society of Nephrology",

issn = "1046-6673",

publisher = "Wolters Kluwer Health",

number = "12",

}

TY - JOUR

T1 - Authors’ Reply

T2 - Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation?

AU - Perico, Norberto

AU - Griffin, Matthew D.

AU - Casiraghi, Federica

AU - Remuzzi, Giuseppe

PY - 2023/12/1

Y1 - 2023/12/1

UR - https://www.scopus.com/pages/publications/85178372576

U2 - 10.1681/ASN.0000000000000231

DO - 10.1681/ASN.0000000000000231

M3 - Letter

C2 - 38039090

AN - SCOPUS:85178372576

SN - 1046-6673

VL - 34

SP - 2052

EP - 2053

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

IS - 12

ER -

Authors’ Reply: Cell Therapies in Diabetic Kidney Disease: Is It Time for Clinical Translation?

UN SDGs

Access to Document

Other files and links

Cite this